Public annual accounts

PHARMACIE GUSTIN financials

A multi-period view of the public annual-account figures reported for PHARMACIE GUSTIN, with comparable measures and links to available source documents.

Company overview
Registry number

0870790477

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

2025 versus 2024

Operating line
€122,521

-49.2%

EBITDA
€25,220

-50.8%

Total assets
€265,567

-5.2%

Equity
€87,333

+20.7%

EBITDA margin +20.6% · Equity ratio +32.9%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO
Fiscal year
Gross margin
EBITDA
Total assets
Equity
Filing
202531 Dec 2025€122,521€25,220€265,567€87,333-
202431 Dec 2024€241,071€51,294€280,195€72,374-
Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report
PHARMACIE GUSTIN financials and annual accounts | Upswitch